Accomplishments in 2008 in the treatment of metastatic pancreatic cancer.
Overview of the DiseaseIncidencePrognosisCurrent Treatment StandardsCytotoxic TherapyTargeted TherapySalvage TherapyAccomplishments or Lack of AccomplishmentsTherapySalvage TherapyBiomarkersApplication of the AccomplishmentsFuture DirectionsCurrent Basic ResearchOngoing Clinical StudiesMajor Obstacles to Progress in Drug DevelopmentGemcitabine PlatformChoice of Molecular TargetsPatient Selection.
Heinemann
Volker
V
Department of Medical Oncology, Ludwig-Maximilian-University of Munich, Munich, Germany.
Philip
Philip A
PA
Pelzer
Uwe
U